• Wellington, K., & Scott, L. J. (2003). Azelnidipine. Drugs, 63(23), 2613-2621. https://pubmed.ncbi.nlm.nih.gov/14636080/
• Chen, B. L., Zhang, Y. Z., Luo, J. Q., & Zhang, W. (2015). Clinical use of azelnidipine in the treatment of hypertension in Chinese patients. Therapeutics and clinical risk management, 309-318. https://pmc.ncbi.nlm.nih.gov/articles/PMC4348133/
• Zhao, X., Wu, F., Jia, S., Qu, P., Li, H., Zhao, X., ... & Wang, M. (2010). Azelnidipine and amlodipine: a comparison of their effects and safety in a randomized double-blinded clinical trial in Chinese essential hypertensive patients. Clinical and Experimental Hypertension, 32(6), 372-376. https://pubmed.ncbi.nlm.nih.gov/21029001/
• Chen, J. H., Cheng, J. J., Chen, C. Y., Chiou, H. C., Huang, T. Y., Tsai, C. D., ... & Cherng, W. J. (2004). Comparison of the efficacy and tolerability of telmisartan 40 mg vs. enalapril 10 mg in the treatment of mild‐to‐moderate hypertension: a multicentre, double‐blind study in Taiwanese patients. International Journal of Clinical Practice, 58, 29-34. https://pubmed.ncbi.nlm.nih.gov/15617456/
• Gosse, P. (2006). A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours. Vascular health and risk management, 2(3), 195-201. https://pubmed.ncbi.nlm.nih.gov/17326326/